VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1548041
Sex: F
Age: 62
State: NJ

Vax Date: 01/26/2021
Onset Date: 01/29/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cold sores; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (cold sores) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. No medical history was provided by reporter. Concomitant products included VALACICLOVIR HYDROCHLORIDE (VALTREX) for Cold sores. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced ORAL HERPES (cold sores). At the time of the report, ORAL HERPES (cold sores) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: VALTREX

Current Illness:

ID: 1548042
Sex: M
Age:
State: LA

Vax Date: 02/17/1971
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nausea; Headache; Fever of 100.4 degree F; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever of 100.4 degree F) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by reporter. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), METOPROLOL and CLOPIDOGREL for an unknown indication. On 17-Feb-1971, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever of 100.4 degree F). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache) and PYREXIA (Fever of 100.4 degree F) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, Body temperature: 100.4 degrees f abnormal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment was taken by the patient.

Other Meds: ASPIRIN (E.C.); METOPROLOL; CLOPIDOGREL

Current Illness:

ID: 1548043
Sex: F
Age: 39
State: NY

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Anxiety/depression worse since these headaches after COVID shot; Anxiety/depression worse since these headaches after COVID shot; Left eye pain; ear pressure; Bad headache in temple area/pain fluctuating to temples, top of head, back to head and sides of head/intense dailypressure headache; exhaustion/extreme fatigue; left side face pain/sided nose and facial pain; Severe pressure in head/facial pain/pressure; Pressure behind eye; Floaters in my eye; Vaccine administered subsutaneously; chills; Low grade temperature; This spontaneous case was reported by an other health care professional and describes the occurrence of FACIAL PAIN (left side face pain/sided nose and facial pain), HEAD DISCOMFORT (Severe pressure in head/facial pain/pressure), OCULAR DISCOMFORT (Pressure behind eye), VITREOUS FLOATERS (Floaters in my eye) and EYE PAIN (Left eye pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy, Anxiety since February 2019, Drug allergy, Drug allergy and Depression since February 2019. Concomitant products included DULOXETINE for Anxiety and Depression, ASCORBIC ACID (VITAMIN C ACID), VITAMIN D NOS and PROBIOTICS NOS for an unknown indication. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 11-Jan-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Vaccine administered subsutaneously). On 13-Jan-2021, the patient experienced FACIAL PAIN (left side face pain/sided nose and facial pain), HEAD DISCOMFORT (Severe pressure in head/facial pain/pressure), OCULAR DISCOMFORT (Pressure behind eye), VITREOUS FLOATERS (Floaters in my eye) and FATIGUE (exhaustion/extreme fatigue). On 13-Jan-2021 at 6:30 AM, the patient experienced EYE PAIN (Left eye pain) and EAR DISCOMFORT (ear pressure). 13-Jan-2021 at 6:30 AM, the patient experienced HEADACHE (Bad headache in temple area/pain fluctuating to temples, top of head, back to head and sides of head/intense dailypressure headache). In January 2021, the patient experienced CHILLS (chills). January 2021, the patient experienced PYREXIA (Low grade temperature). On an unknown date, the patient experienced ANXIETY (Anxiety/depression worse since these headaches after COVID shot) and DEPRESSION (Anxiety/depression worse since these headaches after COVID shot). The patient was treated with METHYLPREDNISOLONE (MEDROL DOSEPAK) for Adverse event, at a dose of 1 dosage form and IBUPROFEN for Adverse event, at a dose of 1 dosage form. On 11-Jan-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Vaccine administered subsutaneously) had resolved. At the time of the report, FACIAL PAIN (left side face pain/sided nose and facial pain), HEAD DISCOMFORT (Severe pressure in head/facial pain/pressure), OCULAR DISCOMFORT (Pressure behind eye), VITREOUS FLOATERS (Floaters in my eye), FATIGUE (exhaustion/extreme fatigue) and CHILLS (chills) outcome was unknown, EYE PAIN (Left eye pain), EAR DISCOMFORT (ear pressure), ANXIETY (Anxiety/depression worse since these headaches after COVID shot), DEPRESSION (Anxiety/depression worse since these headaches after COVID shot) and HEADACHE (Bad headache in temple area/pain fluctuating to temples, top of head, back to head and sides of head/intense dailypressure headache) had not resolved and PYREXIA (Low grade temperature) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 antibody test: negative (Negative) Negative. mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosing remained unchanged. For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter considered EYE PAIN (Left eye pain), EAR DISCOMFORT (ear pressure) and HEADACHE (Bad headache in temple area/pain fluctuating to temples, top of head, back to head and sides of head/intense dailypressure headache) to be related. No further causality assessments were provided for FACIAL PAIN (left side face pain/sided nose and facial pain), HEAD DISCOMFORT (Severe pressure in head/facial pain/pressure), OCULAR DISCOMFORT (Pressure behind eye), VITREOUS FLOATERS (Floaters in my eye), ANXIETY (Anxiety/depression worse since these headaches after COVID shot), DEPRESSION (Anxiety/depression worse since these headaches after COVID shot), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Vaccine administered subsutaneously), FATIGUE (exhaustion/extreme fatigue), CHILLS (chills) and PYREXIA (Low grade temperature). Description. On 29 Jan 2021, the patient saw emergency room, and the health care provider thought it to be side effects of COVID vaccine. The patient tried Methylprednisolone but no change. On 01 Feb 2021, the patient saw allergist who just gave another Methylprednisolone which did not help. Other treatment medications included antibiotics, decongestant. This case was linked to MOD-2021-111164 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: The follow up received updated patient's information, medical history, new events and concomitant medications added, first dose date and action taken updated.

Other Meds: DULOXETINE; VITAMIN C ACID; VITAMIN D NOS; PROBIOTICS NOS.

Current Illness: Anxiety; Depression; Drug allergy.

ID: 1548044
Sex: F
Age: 49
State: AR

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: high blood pressure; Anxiousness; shaking; chills; Sore arm; A spontaneous report was received from a consumer concerning a 49-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a sore arm, chills, shaking, anxiousness and high blood pressure (175/115). No relevant concomitant medications were reported. On 19 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (027L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 19 Jan 2021, the patient experienced a sore arm, chills, shaking, anxiousness and high blood pressure (175/115). Treatment for the events included Tylenol. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events sore arm, chills, shaking, anxiousness and high blood pressure (175/115) was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1548045
Sex: F
Age: 94
State: NJ

Vax Date: 02/15/2021
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash under her right breast; A spontaneous report was received from a consumer concerning her mother, a 94-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rash under her right breast/rash. The patient's medical history was not provided. No relevant concomitant medications were reported. On 15 Feb 2021, prior to the onset of the events the patient received their dose of two planned doses of mRNA-1273 (lot/batch: 011M20A) via unknown route for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced rash under her right breast which was about 4 by 21/2 inches in diameter. The rash was not itchy nor hurting. No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown. The outcome of event rash under her right breast was unknown.

Other Meds:

Current Illness:

ID: 1548046
Sex: F
Age: 68
State: OK

Vax Date: 01/22/2021
Onset Date: 02/02/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: delayed injection site fever; arm sore; delayed injection site bad itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (delayed injection site fever), VACCINATION SITE PRURITUS (delayed injection site bad itching) and VACCINATION SITE PAIN (arm sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no reported medical history). On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (delayed injection site bad itching). On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (delayed injection site fever) and VACCINATION SITE PAIN (arm sore). At the time of the report, VACCINATION SITE WARMTH (delayed injection site fever), VACCINATION SITE PRURITUS (delayed injection site bad itching) and VACCINATION SITE PAIN (arm sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported Treatment for the events included ice and hydrocortisone cream.

Other Meds:

Current Illness:

ID: 1548047
Sex: F
Age:
State: CA

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Muscular pain in back and in back of thighs; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscular pain in back and in back of thighs) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZ0A) for COVID-19 vaccination. No medical History was provided by reporter. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced MYALGIA (Muscular pain in back and in back of thighs). At the time of the report, MYALGIA (Muscular pain in back and in back of thighs) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported

Other Meds:

Current Illness:

ID: 1548048
Sex: F
Age: 72
State: IL

Vax Date: 02/09/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red itchy rash; Red itchy rash; A spontaneous report was received from a consumer concerning a 72-years-old female patient who received first dose of Moderna's COVID-19 vaccine (mRNA-1273) and experienced red itchy rash/ rash pruritic and rash erythematous. The patient's medical history was not provided. No relevant concomitant medications were reported. On 9 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced red itchy rash. No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown. The outcome of event red itchy rash was unknown.

Other Meds:

Current Illness:

ID: 1548049
Sex: F
Age: 67
State: CA

Vax Date: 02/10/2021
Onset Date: 02/11/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headaches in the middle of the night; Muscle aches; Slight fever; Injections site sore; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches in the middle of the night), MYALGIA (Muscle aches), PYREXIA (Slight fever) and VACCINATION SITE PAIN (Injections site sore) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No medical history was provided by reporter. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Muscle aches), PYREXIA (Slight fever) and VACCINATION SITE PAIN (Injections site sore). On 13-Feb-2021, the patient experienced HEADACHE (Headaches in the middle of the night). At the time of the report, HEADACHE (Headaches in the middle of the night), MYALGIA (Muscle aches), PYREXIA (Slight fever) and VACCINATION SITE PAIN (Injections site sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. Treatment details included acetaminophen 250mg/ aspirin 250mg/ caffeine 65mg

Other Meds:

Current Illness:

ID: 1548050
Sex: F
Age: 63
State: VA

Vax Date: 01/04/2021
Onset Date: 02/02/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (couldn't sleep or get comfortable), MYALGIA (body ache) and HEADACHE (headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Jan-2021 at 6:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to dosage form. On 02-Feb-2021, the patient experienced INSOMNIA (couldn't sleep or get comfortable), MYALGIA (body ache) and HEADACHE (headache). At the time of the report, INSOMNIA (couldn't sleep or get comfortable), MYALGIA (body ache) and HEADACHE (headache) outcome was unknown. This case was linked to MOD-2021-103049 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: NNI-Follow up.

Other Meds:

Current Illness:

ID: 1548051
Sex: F
Age: 67
State: MN

Vax Date: 01/20/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness is getting bigger; Warm to the touch Injection Site; White spot near injection site; Swollen Injection Site; Red Injection Site (Around the Arm up to near elbow); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch Injection Site), PAPULE (White spot near injection site), CONDITION AGGRAVATED (Redness is getting bigger), VACCINATION SITE ERYTHEMA (Red Injection Site (Around the Arm up to near elbow)) and VACCINATION SITE SWELLING (Swollen Injection Site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 032H20A) for COVID-19 vaccination. No Medical history was provided by reporter. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red Injection Site (Around the Arm up to near elbow)). On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch Injection Site), PAPULE (White spot near injection site) and VACCINATION SITE SWELLING (Swollen Injection Site). On 20-Feb-2021, the patient experienced CONDITION AGGRAVATED (Redness is getting bigger). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch Injection Site), PAPULE (White spot near injection site), CONDITION AGGRAVATED (Redness is getting bigger), VACCINATION SITE ERYTHEMA (Red Injection Site (Around the Arm up to near elbow)) and VACCINATION SITE SWELLING (Swollen Injection Site) had not resolved. No relevant concomitant medications were reported Treatment details included cetirizine, antibiotics (has not taken yet), and ice pack.

Other Meds:

Current Illness:

ID: 1548052
Sex: F
Age: 74
State: AL

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Back of knee swollen; Hard to stand; Pain in groin; Pain in legs; Achiness in arm; This spontaneous case was reported by a consumer and describes the occurrence of GROIN PAIN (Pain in groin), PAIN IN EXTREMITY (Pain in legs), PAIN IN EXTREMITY (Achiness in arm), JOINT SWELLING (Back of knee swollen) and DYSSTASIA (Hard to stand) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 030M20A) for COVID-19 vaccination. No medical history was provided by reporter. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced GROIN PAIN (Pain in groin), PAIN IN EXTREMITY (Pain in legs) and PAIN IN EXTREMITY (Achiness in arm). On 26-Jan-2021, the patient experienced JOINT SWELLING (Back of knee swollen) and DYSSTASIA (Hard to stand). On 03-Feb-2021, GROIN PAIN (Pain in groin), PAIN IN EXTREMITY (Pain in legs), PAIN IN EXTREMITY (Achiness in arm), JOINT SWELLING (Back of knee swollen) and DYSSTASIA (Hard to stand) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported Treatment details was not provided.

Other Meds:

Current Illness:

ID: 1548053
Sex: F
Age: 51
State: NY

Vax Date: 01/13/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm had swelling/Arm still touchy/Swollen arm; Spent all day in bed; Couldn't move; Painful/ Tender; Hardness at injection site; Chills; Body ache; Headache; Fever; Very tired and fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm had swelling/Arm still touchy/Swollen arm), BEDRIDDEN (Spent all day in bed), HYPOKINESIA (Couldn't move), PAIN (Painful/ Tender) and VACCINATION SITE INDURATION (Hardness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included VALSARTAN, ATORVASTATIN, HYDROCHLOROTHIAZIDE (HCT) and ALPRAZOLAM (XANAX) for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (Body ache), HEADACHE (Headache) and PYREXIA (Fever). On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm had swelling/Arm still touchy/Swollen arm), BEDRIDDEN (Spent all day in bed), HYPOKINESIA (Couldn't move), PAIN (Painful/ Tender), VACCINATION SITE INDURATION (Hardness at injection site) and FATIGUE (Very tired and fatigue). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 11-Feb-2021, CHILLS (Chills), MYALGIA (Body ache), HEADACHE (Headache) and PYREXIA (Fever) had resolved. On 15-Feb-2021, PERIPHERAL SWELLING (Arm had swelling/Arm still touchy/Swollen arm) and VACCINATION SITE INDURATION (Hardness at injection site) had resolved. At the time of the report, BEDRIDDEN (Spent all day in bed), HYPOKINESIA (Couldn't move) and PAIN (Painful/ Tender) outcome was unknown and FATIGUE (Very tired and fatigue) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2021, Body temperature: 100.2 (High) Fever (100.2). This case was linked to MOD-2021-250759 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up received on 26 Apr 2021 and patient's e-mail address updated. On 09-Jul-2021: Follow up received on 09 Jul 2021 included updates in the reported events.

Other Meds: VALSARTAN; ATORVASTATIN; HCT; XANAX

Current Illness:

ID: 1548054
Sex: F
Age: 74
State: AL

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling in back of knee; its hard to stand; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swelling in back of knee) and DYSSTASIA (its hard to stand) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. No Medical History was provided by the reporter. On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced JOINT SWELLING (Swelling in back of knee) and DYSSTASIA (its hard to stand). At the time of the report, JOINT SWELLING (Swelling in back of knee) and DYSSTASIA (its hard to stand) had not resolved. Patient reported non-drug treatment for symptoms included Heat and TENS unit. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1548055
Sex: F
Age: 87
State: OH

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: little bit of a blurry eye; blurry eye which got worse; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (little bit of a blurry eye) and CONDITION AGGRAVATED (blurry eye which got worse) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History was provided by the reporter. On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VISION BLURRED (little bit of a blurry eye) and CONDITION AGGRAVATED (blurry eye which got worse). At the time of the report, VISION BLURRED (little bit of a blurry eye) and CONDITION AGGRAVATED (blurry eye which got worse) was resolving. Concomitant product use was not provided by the reporter. No treatment information was provided. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: NNI

Other Meds:

Current Illness:

ID: 1548056
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Covid arm; A spontaneous report was received from a healthcare professional concerning a 70-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events covid arm. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 028L20A) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced the event(s) covid arm and want to know if there were any report of this during the clinical trial and if the patient can continue to take the 2nd dose of the vaccine. Treatment details included paracetamol. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event covid arm was unknown.

Other Meds:

Current Illness:

ID: 1548057
Sex: F
Age: 71
State: WA

Vax Date: 02/09/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy; Swelling; Red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No medical history was provided by reporter. On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported Treatment details included cortisone

Other Meds:

Current Illness:

ID: 1548058
Sex: F
Age: 65
State: NC

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder; tender/very sore injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (tender/very sore injection site) and ARTHRALGIA (terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by reporter. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (tender/very sore injection site). On 16-Feb-2021, the patient experienced ARTHRALGIA (terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder). At the time of the report, VACCINATION SITE PAIN (tender/very sore injection site) and ARTHRALGIA (terrible pain on her left back (shoulder blade) extending to the armpit and front of the shoulder) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were provided by reporter patient took two doses of Ibuprofen for Treatment. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1548059
Sex: F
Age:
State: IL

Vax Date: 01/26/2021
Onset Date: 01/28/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Chills; Joint pain/ankle pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills) and ARTHRALGIA (Joint pain/ankle pain) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills) and ARTHRALGIA (Joint pain/ankle pain). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills) and ARTHRALGIA (Joint pain/ankle pain) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Initial additional information included updated Email .

Other Meds:

Current Illness:

ID: 1548060
Sex: F
Age: 78
State: FL

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash on the bottom of her feet and legs that were itchy; right arm red; right arm hot; right arm itchy; rash on right arm; fever of 101.5; high blood pressure 105; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 101.5), HYPERTENSION (high blood pressure 105), RASH PRURITIC (rash on the bottom of her feet and legs that were itchy), VACCINATION SITE ERYTHEMA (right arm red) and VACCINATION SITE WARMTH (right arm hot) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by reporter. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PYREXIA (fever of 101.5) and HYPERTENSION (high blood pressure 105). On 17-Feb-2021, the patient experienced RASH PRURITIC (rash on the bottom of her feet and legs that were itchy), VACCINATION SITE ERYTHEMA (right arm red), VACCINATION SITE WARMTH (right arm hot), INJECTION SITE PRURITUS (right arm itchy) and RASH (rash on right arm). On 17-Feb-2021, PYREXIA (fever of 101.5) and HYPERTENSION (high blood pressure 105) had resolved. On 18-Feb-2021, RASH PRURITIC (rash on the bottom of her feet and legs that were itchy) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (right arm red), VACCINATION SITE WARMTH (right arm hot), INJECTION SITE PRURITUS (right arm itchy) and RASH (rash on right arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported Treatment details included Hydrocortisone Cream.

Other Meds:

Current Illness:

ID: 1548061
Sex: F
Age:
State: IL

Vax Date: 02/05/2021
Onset Date: 02/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red splotch on vaccine arm; also noticed splotches on her head and face; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red splotch on vaccine arm) and RASH MACULAR (also noticed splotches on her head and face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029l20a) for COVID-19 vaccination. No medical history was provided by reporter. Concomitant products included METOPROLOL, AMLODIPINE and CHLORTHALIDONE for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE RASH (red splotch on vaccine arm) and RASH MACULAR (also noticed splotches on her head and face). At the time of the report, VACCINATION SITE RASH (red splotch on vaccine arm) and RASH MACULAR (also noticed splotches on her head and face) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment details were provided. Reporter did not allow further contact

Other Meds: METOPROLOL; AMLODIPINE; CHLORTHALIDONE

Current Illness:

ID: 1548062
Sex: F
Age:
State: FL

Vax Date: 02/17/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever(101.6); Fatigue; Headache; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever(101.6)), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (body aches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No medical history was provided by reporter. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PYREXIA (fever(101.6)), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (body aches). At the time of the report, PYREXIA (fever(101.6)), FATIGUE (Fatigue), HEADACHE (Headache) and MYALGIA (body aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported No treatment information was provided.

Other Meds:

Current Illness:

ID: 1548063
Sex: M
Age:
State: NJ

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cough; Chest congestion; Heavy head; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), CHEST DISCOMFORT (Chest congestion), HEAD DISCOMFORT (Heavy head), FATIGUE (Tiredness) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by reporter. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced COUGH (Cough), CHEST DISCOMFORT (Chest congestion), HEAD DISCOMFORT (Heavy head), FATIGUE (Tiredness) and HEADACHE (Headache). At the time of the report, COUGH (Cough), CHEST DISCOMFORT (Chest congestion), HEAD DISCOMFORT (Heavy head), FATIGUE (Tiredness) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1548064
Sex: F
Age: 76
State: PA

Vax Date: 01/28/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: With vasculitis; Extremely painful; Leg was completely red; This spontaneous case was reported by a consumer and describes the occurrence of VASCULITIS (With vasculitis), PAIN IN EXTREMITY (Extremely painful) and ERYTHEMA (Leg was completely red) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011620A) for COVID-19 vaccination. The patient's past medical history included Osteoporosis, Open heart surgery and Blood transfusion (3 blood transfusion in the past). Previously administered products included for an unreported indication: PREDNISONE (For vasculitis (allergy caused by Forteo injection).) in 2001. Concurrent medical conditions included Cryoglobulinemia (She had a mix essential type 2 cryoglobulinemia. She has been in remission for some time.) and Drug allergy (She took Forteo injection for osteoporosis 10 years ago and had a reaction.At that time, she had her waist down covered with vasculitis, and they gave her prednisone to treat.) in 2001. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VASCULITIS (With vasculitis), PAIN IN EXTREMITY (Extremely painful) and ERYTHEMA (Leg was completely red). At the time of the report, VASCULITIS (With vasculitis), PAIN IN EXTREMITY (Extremely painful) and ERYTHEMA (Leg was completely red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details included 1 dose of 20mg prednisone on 18 Feb 2021.

Other Meds:

Current Illness: Cryoglobulinemia (She had a mix essential type 2 cryoglobulinemia. She has been in remission for some time.)

ID: 1548065
Sex: F
Age: 23
State: CA

Vax Date: 01/20/2021
Onset Date: 01/01/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No medical history was provided by reporter. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported

Other Meds:

Current Illness:

ID: 1548066
Sex: F
Age: 34
State:

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot arm; itchy arm; 30 weeks pregnant; tender arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (30 weeks pregnant) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (30 weeks pregnant). On 20-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (30 weeks pregnant) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not reported. Treatment information was not provided. This case was linked to MOD-2021-018462 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: Internal review on 20JUL2021 resulted in updates to pregnancy details.

Other Meds:

Current Illness:

ID: 1548067
Sex: M
Age:
State: MD

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm sore; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 18-Feb-2021. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (Arm sore) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included METFORMIN for an unknown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm sore). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-056485 (Patient Link).

Other Meds: METFORMIN.

Current Illness:

ID: 1548068
Sex: M
Age: 89
State: NY

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash; itching; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) and PRURITUS (itching) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No medical history was provided by reporter. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash) and PRURITUS (itching). At the time of the report, RASH (rash) and PRURITUS (itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported No treatment information was provided.

Other Meds:

Current Illness:

ID: 1548069
Sex: F
Age: 33
State: IL

Vax Date: 02/13/2021
Onset Date: 02/13/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Oct-2020 and the estimated date of delivery was date. On 13-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the sixteenth week of the pregnancy. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1548070
Sex: F
Age: 29
State: MI

Vax Date: 02/11/2021
Onset Date: 02/11/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; This spontaneous retrospective pregnancy case was reported by an other and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 29-year-old female patient (gravida 2, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The patient's past medical history included Depression and Anxiety. Concurrent medical conditions included Drug allergy (drug-cefprozil) and Drug allergy (cefprozil). Concomitant products included ZINGIBER OFFICINALE (GINGERPRO) from 01-Jan-2020 to an unknown date for Nausea and Digestion impaired, DOXYLAMINE from 27-Jul-2020 to 09-Mar-2021 for Nausea and Insomnia, MAGNESIUM from 01-Jan-2019 to an unknown date for Sleeplessness and Constipation, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 01-May-2020 to an unknown date for Vitamin supplementation, DOCOSAHEXAENOIC ACID (OMEGA 3 DHA [DOCOSAHEXAENOIC ACID]) from 01-May-2020 to an unknown date for an unknown indication. On 11-Feb-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 12-Jun-2020 and the estimated date of delivery was 19-Mar-2021. On 11-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-fifth week of the pregnancy. The vaginal delivery occurred on 10-Mar-2021, which was reported as Normal Pregnancy Outcome. For neonate 1, the birth weight was 1388 grams (3lbs 1oz) with an APGAR score of 8 and 9 at (1, 5 minutes). The outcome was reported as Delivered NOS. On 11-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Oct-2020, Ultrasound antenatal screen normal: normal (normal) Normal, no abnormalities founds. On 18-Dec-2020, Glucose tolerance test: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient's reported last menstrual period was 12-Jun-2020, date of positive pregnancy test was on 06-Jun-2020. Meconium stained amniotic fluid without complications was reported. No infant abnormalities were reported during pregnancy and 1 month post-partum. Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: Initial additional - pregnancy outcome form : Added revised patient initial, updated lab data, delivery details and concomitant medications drug information

Other Meds: DOXYLAMINE; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; OMEGA 3 DHA [DOCOSAHEXAENOIC ACID]; MAGNESIUM; GINGERPRO

Current Illness:

ID: 1548071
Sex: F
Age: 68
State: OR

Vax Date: 02/15/2021
Onset Date: 02/16/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling on two fingers on her right hand; Itching; Red spots; A spontaneous report was received from a consumer concerning a 68-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swelling on two fingers on her right hand / peripheral swelling, red spots / erythema and itching / pruritus. The patient's medical history and concomitant product use was not provided by the reporter. On 15 Feb 2021, approximately one day prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 16 Feb 2021, patient experienced the events, swelling on two fingers on her right hand, red spots and itching. Treatment for the events included naproxen and cortisone. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events, swelling on two fingers on her right hand, red spots and itching was unknown.; Reporter's Comments: Based on the current available information which includes a temporal association between the use of the product and the start date of the reported events, a causal relationship with the event cannot be excluded.

Other Meds:

Current Illness:

ID: 1548072
Sex: F
Age: 88
State: CA

Vax Date: 02/12/2021
Onset Date: 02/13/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; Body pain; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PAIN (Body pain) and DIARRHOEA (Diarrhea) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). Concomitant products included TRAMADOL, Diazepam as needed and DULOXETINE for an unknown indication. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN (Body aches), PAIN (Body pain) and DIARRHOEA (Diarrhea). At the time of the report, PAIN (Body aches), PAIN (Body pain) and DIARRHOEA (Diarrhea) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient didn't receive any treatment her symptoms subsided.

Other Meds: TRAMADOL; Diazepam as needed; DULOXETINE

Current Illness:

ID: 1548073
Sex: F
Age: 20
State: TX

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for covid-19) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for covid-19). At the time of the report, COVID-19 (Tested positive for covid-19) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication included Birth Control . Treatment details were not provided.; Reporter's Comments: Based on reporter's causality the event is assessed as unlikely related to mRNA-1273. The event of COVID-19 is unlikely related to mRNA-1273 since the vaccine does not contain virus capable of causing infection.

Other Meds:

Current Illness:

ID: 1548074
Sex: U
Age:
State: ID

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: term a little bit of tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (term a little bit of tenderness) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03IL20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included LOSARTAN, ATORVASTATIN, METFORMIN, LEVOTHYROXINE and FISH OIL for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced TENDERNESS (term a little bit of tenderness). At the time of the report, TENDERNESS (term a little bit of tenderness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no treatment given

Other Meds: LOSARTAN; ATORVASTATIN; METFORMIN; LEVOTHYROXINE; FISH OIL

Current Illness:

ID: 1548075
Sex: F
Age: 78
State: MA

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (light headache), DIZZINESS (dizziness), DECREASED APPETITE (loss of appetite), FATIGUE (tiredness) and NIGHT SWEATS (night sweats) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced HEADACHE (light headache), DIZZINESS (dizziness), DECREASED APPETITE (loss of appetite) and FATIGUE (tiredness). On 15-Feb-2021, the patient experienced NIGHT SWEATS (night sweats). On 18-Feb-2021, HEADACHE (light headache), DIZZINESS (dizziness), DECREASED APPETITE (loss of appetite), FATIGUE (tiredness) and NIGHT SWEATS (night sweats) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient has taken Tylenol which subsided the adverse events.

Other Meds:

Current Illness:

ID: 1548076
Sex: F
Age:
State: ND

Vax Date: 12/31/2020
Onset Date: 01/25/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 36-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L202A and 205J202A) for COVID-19 vaccination. The patient's past medical history included Asthma, Leiomyosarcoma (cancer) and Infertility. Concurrent medical conditions included Pregnancy since 11-Feb-2021 and Kidney absent (since birth). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Vitamin supplementation, ESTROGEN NOS and VITAMIN D NOS (VITAMIN D NOS 3000 iu) for an unknown indication, PROGESTERONE. On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 10-Jan-2021 and the estimated date of delivery was 20-Oct-2021. On 25-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the second week of the pregnancy. The delivery occurred on an unknown date. For neonate 1, Estimated date of conception-02-02-2021. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Pregnancy test positive: positive positive positive. no treatment given no concomitant provide

Other Meds: ESTROGEN NOS; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; VITAMIN D NOS 3000 iu; PROGESTERONE

Current Illness: Pregnancy

ID: 1548077
Sex: F
Age:
State: NY

Vax Date: 02/11/2021
Onset Date: 02/12/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site arm spots that are itchy; Injection site slightly swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site arm spots that are itchy) and VACCINATION SITE SWELLING (Injection site slightly swollen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site arm spots that are itchy) and VACCINATION SITE SWELLING (Injection site slightly swollen). At the time of the report, VACCINATION SITE PRURITUS (Injection site arm spots that are itchy) and VACCINATION SITE SWELLING (Injection site slightly swollen) outcome was unknown. no concomitant medication provided no treatment given

Other Meds:

Current Illness:

ID: 1548078
Sex: M
Age: 51
State: GA

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muddled feeling; chills that come and go; nausea; injection site painful; injection site itchy; injection site is red; weird headache; arm pain; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (muddled feeling), CHILLS (chills that come and go), NAUSEA (nausea), INJECTION SITE PAIN (injection site painful) and INJECTION SITE PRURITUS (injection site itchy) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. patient will call back to add) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no history provided). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (muddled feeling), CHILLS (chills that come and go), NAUSEA (nausea), INJECTION SITE PAIN (injection site painful), INJECTION SITE PRURITUS (injection site itchy), INJECTION SITE ERYTHEMA (injection site is red), HEADACHE (weird headache) and LIMB DISCOMFORT (arm pain). At the time of the report, CONFUSIONAL STATE (muddled feeling), NAUSEA (nausea), INJECTION SITE PAIN (injection site painful), INJECTION SITE ERYTHEMA (injection site is red), HEADACHE (weird headache) and LIMB DISCOMFORT (arm pain) outcome was unknown and CHILLS (chills that come and go) had resolved. no concomitant medication provided patient has taken treatment ibuprofen

Other Meds:

Current Illness:

ID: 1548079
Sex: F
Age: 62
State: AL

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lymph nodes around the base of her neck, base of her skull and around her clavicle are hurting; muscle soreness; lymph nodes are tender; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph nodes around the base of her neck, base of her skull and around her clavicle are hurting), MYALGIA (muscle soreness), LYMPH NODE PAIN (lymph nodes are tender), CHILLS (chills) and PAIN (body aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. D30M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history). On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes around the base of her neck, base of her skull and around her clavicle are hurting), MYALGIA (muscle soreness), LYMPH NODE PAIN (lymph nodes are tender), CHILLS (chills) and PAIN (body aches). At the time of the report, LYMPHADENOPATHY (Lymph nodes around the base of her neck, base of her skull and around her clavicle are hurting), MYALGIA (muscle soreness), LYMPH NODE PAIN (lymph nodes are tender), CHILLS (chills) and PAIN (body aches) outcome was unknown. no concomitant medication Patient has taken treatment tylenol

Other Meds:

Current Illness:

ID: 1548080
Sex: F
Age: 37
State: PA

Vax Date: 01/27/2021
Onset Date: 01/22/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant Received 2 doses of vaccine; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant Received 2 doses of vaccine) in a 38-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 013L20A) for COVID-19 vaccination. The patient's past medical history included Obesity in 2011. Concurrent medical conditions included Asthma, Hypertension since 2016, Hypothyroidism since 2015 and Pregnancy (Due date-01-09-2021) since 31-Dec-2020. Concomitant products included LEVOTHYROXINE, VITAMIN D NOS, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT inhaler), NIFEDIPINE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN + HIDROCLOROTIAZIDA) and HYDRALAZINE for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 25-Nov-2020 and the estimated date of delivery was 01-Sep-2021. On 22-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant Received 2 doses of vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twelfth week of the pregnancy. On 22-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant Received 2 doses of vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Dec-2020, Pregnancy test positive: positive (Positive) positive. no treatment provided. Estimated date of conception was 07 Dec 2021.

Other Meds: LEVOTHYROXINE; VITAMIN D NOS; SYMBICORT inhaler; NIFEDIPINE; LOSARTAN + HIDROCLOROTIAZIDA; HYDRALAZINE

Current Illness: Asthma; Hypertension; Hypothyroidism; Pregnancy (Due date-01-09-2021)

ID: 1548081
Sex: F
Age: 29
State: NV

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 29-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 012M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. The patient's last menstrual period was on 10-Dec-2020 and the estimated date of delivery was 16-Sep-2021. On 09-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the fourth week of the pregnancy. On 09-Jan-2021, EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Ultrasound foetal: normal normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1548082
Sex: M
Age: 70
State: NH

Vax Date: 02/03/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). Concomitant products included ALBUTEROL SULFATE (ALBUTEROL SULFATE Inhalation When needed) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT inhaler) for an unknown indication. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. patient has given Inhaler and Usenix

Other Meds: ALBUTEROL SULFATE Inhalation When needed; SYMBICORT inhaler

Current Illness:

ID: 1548083
Sex: F
Age: 35
State: TX

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Aches; Sore arm; Chills; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Aches), EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), MYALGIA (Sore arm) and CHILLS (Chills) in a 36-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 022M20A) for COVID-19 vaccination. The patient's past medical history included Pregnancy (No complications and live, full-term birth.) on 28-Feb-2018. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 27-May-2020 and the estimated date of delivery was 03-Mar-2021. On 16-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 13-Feb-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Aches), MYALGIA (Sore arm) and CHILLS (Chills). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-third week of the pregnancy. The delivery occurred on 28-Feb-2018, which was reported as Full-term. For neonate 1, The outcome was reported as Delivered NOS. Live, full-term birth. The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 13-Feb-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. At the time of the report, PAIN IN EXTREMITY (Aches), MYALGIA (Sore arm) and CHILLS (Chills) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Glucose tolerance test: normal (normal) normal. On an unknown date, Ultrasound scan: normal (normal) normal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-018518 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: Internal review conducted on 23-Jul-2021 resulted in updates to pregnancy information.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS.]

Current Illness:

ID: 1548084
Sex: M
Age: 67
State: FL

Vax Date: 02/02/2021
Onset Date: 02/04/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: loss of taste; loss of smell; symptoms similar to a sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste), ANOSMIA (loss of smell) and SINUSITIS (symptoms similar to a sinus infection) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced AGEUSIA (loss of taste), ANOSMIA (loss of smell) and SINUSITIS (symptoms similar to a sinus infection). At the time of the report, AGEUSIA (loss of taste), ANOSMIA (loss of smell) and SINUSITIS (symptoms similar to a sinus infection) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no treatment has provided no concomitant medication has given This case was linked to MOD-2021-016500 (Patient Link).

Other Meds:

Current Illness:

ID: 1548085
Sex: M
Age: 75
State: AZ

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Burning shoulder; stiff neck; A rash at the right side of the chest; aching arm; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (aching arm), MUSCULOSKELETAL DISCOMFORT (Burning shoulder), MUSCULOSKELETAL STIFFNESS (stiff neck) and RASH (A rash at the right side of the chest) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history found). On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (aching arm). On 12-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Burning shoulder), MUSCULOSKELETAL STIFFNESS (stiff neck) and RASH (A rash at the right side of the chest). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), PAIN IN EXTREMITY (aching arm), MUSCULOSKELETAL DISCOMFORT (Burning shoulder) and MUSCULOSKELETAL STIFFNESS (stiff neck) was resolving and RASH (A rash at the right side of the chest) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no concomitant medication provided

Other Meds:

Current Illness:

ID: 1548086
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: heart palpitation; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart palpitation). At the time of the report, PALPITATIONS (heart palpitation) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. no treatment provided no concomitant medication given

Other Meds:

Current Illness:

ID: 1548087
Sex: F
Age: 68
State: FL

Vax Date: 01/21/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: She took a COVID-19 test and tested positive; fever; coughing; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (coughing), PYREXIA (fever) and COVID-19 (She took a COVID-19 test and tested positive) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced COUGH (coughing). On 12-Feb-2021, the patient experienced PYREXIA (fever). On 13-Feb-2021, the patient experienced COVID-19 (She took a COVID-19 test and tested positive). At the time of the report, COUGH (coughing), PYREXIA (fever) and COVID-19 (She took a COVID-19 test and tested positive) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Pyrexia: 12-feb-21 (High) 100.4. On 13-Feb-2021, SARS-CoV-1 test positive: positive positive (Positive) positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. no concomitant medication and treatment provided. Schedule for 2 dose 18-feb-2021, she tested positive and pharmacist has said to finish her quarantine before she gets 2 dose.

Other Meds:

Current Illness:

ID: 1548088
Sex: F
Age: 79
State: FL

Vax Date: 02/10/2021
Onset Date: 02/10/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in the muscle area where she got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (pain in the muscle area where she got the vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). Concomitant products included BUSPIRONE, DULOXETINE, LAMOTRIGINE, TOPIRAMATE, c-Dextro HBR, IBUPROFEN, METHOCARBAMOL, PARACETAMOL (EXTRA STRENGTH TYLENOL BACK PAIN), GABAPENTIN, METOLAZONE, BUMETANIDE (BUMEX), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), L-METHYLFOLATE, LURASIDONE, LEVOTHYROXINE, SPIRONOLACTONE, SUVOREXANT (BELSOMRA), TRIAMCINOLONE ACETONIDE (NASACORT), MACROGOL 3350 (DULCOLAX BALANCE), GUAIFENESIN (MUCINEX) and MECOBALAMIN (B12 SHOT) for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced MYALGIA (pain in the muscle area where she got the vaccine). At the time of the report, MYALGIA (pain in the muscle area where she got the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment given

Other Meds: BUSPIRONE; DULOXETINE; LAMOTRIGINE; TOPIRAMATE; c-Dextro HBR; IBUPROFEN; EXTRA STRENGTH TYLENOL BACK PAIN; GABAPENTIN; METOLAZONE; BUMEX; ZYRTEC ALLERGY; L-METHYLFOLATE; LURASIDONE; LEVOTHYROXINE; SPIRONOLACTONE; BELSOMRA; NASACORT; DULCOLA

Current Illness:

ID: 1548089
Sex: F
Age:
State:

Vax Date: 02/16/2021
Onset Date: 02/17/2021
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red injection site that's getting bigger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (no medical history provided). On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red injection site that's getting bigger). At the time of the report, VACCINATION SITE ERYTHEMA (red injection site that's getting bigger) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medication and treatment provided.

Other Meds:

Current Illness:

ID: 1548090
Sex: F
Age:
State:

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/12/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild side effects; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Mild side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Mild side effects). At the time of the report, ADVERSE DRUG REACTION (Mild side effects) outcome was unknown. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable No concomitant medication were reported No treatment medication were reported.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm